Altus Drug Development

JUNE 28, 2022

For instance, European pediatric regulation places certain requirements to support the safety and efficacy of drugs destined to be used on children ( source ). Drug repositioning has become a strategic research approach when treating neglected diseases. To comply with the law.

Pharmaceutical Companies

The Pharma Data

DECEMBER 17, 2020

Most recently, Cadavid served as senior vice president and Head of Clinical Development at Fulcrum Therapeutics where he led the development of multiple small molecules for the treatment of genetically defined rare diseases. AB2 Bio – Swiss pharma company AB2 Bio Ltd. Immune Regulation – U.K.-based

Small Molecule

Codon

FEBRUARY 13, 2024

alone, according to the Centers for Disease Control and Prevention. But one can only train a phage so much before it has changed, genetically, to the point where it is now considered a different phage to the one the regulator initially approved. At least a million people die from drug-resistant bacterial infections every year.

Therapies

The Pharma Data

MAY 14, 2021

First, most are on the payroll of the big pharma companies earning lucrative commissions for pushing their drugs…. Shockingly, in many cases, many medications have been found to progress the disease. The second reason is even more common…. Often to the point of no return…. …The liver is equally important.

Doctors

The Anticancer Fund

JUNE 7, 2022

In the therapeutic study in patients with recurrent and/or metastatic disease (n=12), treatment was shown to be tolerable but there was no signal of efficacy, with median PFS less than two months in 9 evaluable patients. These findings raise more questions of course, but for those of us in repurposing this data-driven approach is welcome.

Drugs

Agency IQ

JULY 12, 2024

BY LAURA DIANGELO, MPH | JUL 10, 2024 3:47 PM CDT Regulatory background: The FDA is responsible for overseeing information about regulated products. The FDA is responsible for ensuring that medical products are adequately labeled in accordance with federal regulations, including the product’s “intended use” and relevant safety information.

FDA

The Pharma Data

MAY 13, 2021

Unfortunately, I learned the hard way that the “Big Pharma” companies don’t care about their patients. A piece of technology, originally designed to be used on plants, had medical implications for humans here on earth to treat illness, disease and pain. It’s all about the bottom line, at any cost.

Pharmacy

The Pharma Data

DECEMBER 30, 2020

The reason for this is still not understood and many regulators may want it to be explained before authorizing it for broader use. One way or the other, Biogen’s aducanumab for Alzheimer’s disease is likely to be a big story in 2021. Four big companies are cited as possible tasty takeover targets for 2021. .

Vaccine

Drug Target Review

MARCH 13, 2025

The journey from distrust to collaboration among industry, academia and regulators will expedite integration, minimise clinical failures and enhance economic sustainability. Techbio companies have initiated this approach. FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine.

Drug Development